APIs vertically integrated
Out-licensing options with FC BU API
API
Strength
Formulation
Alendronate
70mg
Tablets
Candesartan + hydrochlorothiazide
(dossier under development)
(dossier under development)
8mg + 12.5mg, 16mg + 12.5mg
Tablets
Enalapril + hydrochlorothiazide
20mg + 12.5mg
Tablets
Irbesartan + hydrochlorothiazide
150mg + 12.5mg, 300mg + 12.5mg
Film-coated tablets
Montelukast sodium
4mg, 5mg
Chewable tablets
Montelukast sodium
10mg
Film-coated tablets
Piracetam
1g / 5ml, 3g / 15ml
Solution for injection
Sildenafil citrate
25mg, 50mg, 100mg
Tablets
Valsartan + hydrochlorothiazide
80mg + 12.5mg, 160mg +12.5mg,
160mg + 25mg
160mg + 25mg
Film-coated tablets
Zoledronic acid
(dossier under development)
(dossier under development)
4mg / 5ml
Powder for concentrate for infusion
APIs which can be vertically integrated on request: topiramate and metoprolol succinate.
See Intellectual Property Disclaimer
For complete dossier list please contact:
Polpharma Out-licensing
phone: +48 22 364 61 00
e-mail:
Latest news
CEP for Baclofen available
Monday, 02-01-2012
Polpharma has been granted Certificate of Suitability (CEP) by the European Directorate for the Quality of...
Polpharma – the most innovative company in Poland
Friday, 20-05-2011
Polpharma ranked first as the most innovative company in Poland, in a research study run by the Institute...